UBE2NP1

Across TCGA pan-cancer cohorts, UBE2NP1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated UBE2NP1 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher UBE2NP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBE2NP1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and READ show a favorable association.

THCA, UCEC, and KICH are the cancer types where UBE2NP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Quartile	All	0.949	0.994	.007	60	view →
UCEC	DFS	Tertile	III,IV	0.888	0.729	.008	30	view →
KICH	OS	Tertile	All	0.636	0.926	.005	28	view →
READ	DFS	Quartile	II,III,IV	0.903	0.412	.006	23	view →
MESO	OS	Quartile	IV	0.161	0.681	<.001	21	view →
LIHC	OS	Tertile	II,III,IV	0.512	0.651	.030	18	view →
HNSC	DFS	Quartile	II,III,IV	0.545	0.277	.011	16	view →
GBM	DFS	Median	All	0.375	0.185	.003	15	view →
CESC	OS	Quartile	IV	0.369	0.619	.033	12	view →
DLBC	DFS	Quartile	II,III,IV	0.462	0.951	.026	6	view →
COAD	OS	Tertile	All	0.936	0.853	.022	4	view →
PCPG	OS	Quartile	All	0.804	1.000	.016	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

UBE2NP1–THCA (OS)

Open the THCA breakdown →